Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -9.163% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) CCN1CCN(CC(O)COCC2COc3ccccc3O2)CC1.Cl
(b) COc1cccc2cc(C(N)=O)/c(=N/NC(=O)COc3ccc(Cl)cc3)oc12
(c) CCCCOc1ccc(C(=O)N2CCN(c3ncccn3)CC2)cc1
(d) Nc1c2c(nc3ccccc13)CCCC2=O.O=C(O)CCC(=O)O
(e) COc1ccc(NC(=O)N2CCN(C(=O)C(Cc3ccc(F)cc3)NC(C)=O)CC2)cc1
Answer: c. CCCCOc1ccc(C(=O)N2CCN(c3ncccn3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCOc1ccc(C(=O)N2CCN(c3ncccn3)CC2)cc1
CCCCOc1ccc(C(=O)N2CCN(c3ncccn3)CC2)cc1
(4-butoxyphenyl)-(4-pyrimidin-2-ylpiperazin-1-yl)methanone